Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
5th International IBD Meeting - Capri, Italy - 8-10 April, 2010
BIO 2010 - Chicago, USA - May 3-6, 2010